Broad clinical programme
Tirzepatide was evaluated in the SURPASS (type 2 diabetes) and SURMOUNT (weight management) programmes, with thousands of participants and peer-reviewed publications.
Information, provenance and support for those looking for Tirzena in Paraguay, with options for individual and higher-volume purchases, subject to availability and applicable law.
Tirzena is a medicine whose active ingredient is tirzepatide. Review the technical information before any treatment decision.
Tirzepatide is a dual-acting molecule, an agonist of the GIP and GLP-1 receptors — two receptors involved in glucose regulation, insulin secretion and satiety.
Approved indications vary according to each product's marketing authorisation and each country. In several countries, tirzepatide-based medicines are approved for type 2 diabetes management and, in certain presentations and jurisdictions, for weight management in patients who meet defined clinical criteria.
Scientific information is not a commercial promise. This page presents what the clinical literature describes and how to obtain the product safely and lawfully — indication, dose and follow-up are always the responsibility of a licensed healthcare professional.
Dual GIP and GLP-1 receptor agonism, as described in the scientific literature.
Prescription medicine: a medical assessment determines whether treatment is appropriate.
Dose titration, monitoring and adverse-event management require professional supervision.
Balanced nutrition, physical activity and professional follow-up remain essential.
Because it is one of the most studied and effective therapies available for certain indications, according to clinical evidence published in peer-reviewed journals.
Tirzepatide was evaluated in the SURPASS (type 2 diabetes) and SURMOUNT (weight management) programmes, with thousands of participants and peer-reviewed publications.
In the SURPASS trials, published in The Lancet and the New England Journal of Medicine, significant HbA1c reductions were observed versus the comparators studied.
In SURMOUNT-1 (Jastreboff et al., NEJM, 2022), mean body-weight reductions of 15% to 20.9% at 72 weeks were reported, depending on dose, in adults with obesity without diabetes.
Dual GIP/GLP-1 agonism acts on glucose-dependent insulin secretion, gastric emptying and appetite regulation.
The most frequently reported adverse events were gastrointestinal (nausea, diarrhoea, vomiting). Relevant contraindications are listed in the label, including a personal or family history of medullary thyroid carcinoma and MEN type 2.
All benefits described in trials were obtained within a context of prescription, dose titration and structured clinical follow-up.
Results vary from person to person and treatment must be prescribed and monitored by a licensed professional. The data above refer to populations studied in clinical trials and are not a promise of individual results.
What we offer to those seeking information and lawful purchase of Tirzena in Paraguay.
Communication based on published, peer-reviewed studies — without overstatement.
A molecule developed with dual-action peptide technology.
GIP/GLP-1 agonism described and documented in the scientific literature.
Verification of origin, batch, expiry date and packaging integrity.
A team prepared to advise on availability and purchase requirements.
Clear information on prescription and applicable regulation.
Service for legally authorised parties in higher-volume operations.
These are service differentiators and do not constitute any guarantee of therapeutic outcome.
We serve parties interested in higher-volume purchases — distributors, establishments and commercial operations that are legally authorised to acquire and handle medicines.
Medicines require an intact chain of custody. These are the points to check in any purchase.
Identify the manufacturer and the supply chain up to the point of sale.
The batch number must be legible on the packaging and match the documentation.
Check the printed expiry date and refuse expired products or unreadable dates.
Check seals, carton integrity and the absence of tampering signs.
Tirzepatide requires refrigeration as per the label; the cold chain must be maintained.
Request the documents required by regulation for the type of operation.
Deal only through identified channels. Our official channel is the WhatsApp number below.
How the lawful purchase of tirzepatide works in Paraguay.
In Paraguay, medicines such as Tirzena (tirzepatide) are prescription products and their commercialisation is subject to national health regulation, overseen by DINAVISA (Dirección Nacional de Vigilancia Sanitaria).
For a lawful purchase, the buyer must hold a prescription from a licensed professional, purchase through identified channels and verify the product's provenance (manufacturer, batch, expiry date and packaging integrity).
For higher-volume purchases, the buyer must additionally be legally authorised as an establishment or commercial operation permitted to acquire and handle medicines.
Anyone intending to take the product to another country must first check import requirements, quantity limits and documentation required by the destination health authority. We do not advise or support any practice outside applicable law.
The information in this section is general in nature and does not replace consulting current regulation or a licensed professional.
Objective answers to the most searched questions.
Talk to our team on WhatsApp and get information about availability, purchase conditions, provenance and acquisition requirements.
Consult a healthcare professional to find out whether this treatment is appropriate for you.
WhatsApp +595 973 919 257 · contato@tirzenaparaguay.com